SMMT

Summit Therapeutics Inc.

NasdaqGM · Healthcare

$13.02

+5.48% today

last filing 2026-06-12Pro sees filings in ~15 min

Price

hover · 4 moves explained

13 buys50 8-K

Analyst consensus

Buy

$28.56target+119.3%vs $13.02 today

$7.67 low today target$44.84 high

13 analysts · ~12-month consensus · as of Jun 4. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 1 of last 4

Earnings per share · actual vs forecast

Q2 '25

−$0.57

exp −$0.07

Q3 '25

−$0.23

exp −$0.04

Q4 '25

−$0.21

exp −$0.01

Q1 '26+14.2%

−$0.18

exp −$0.21

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Buy	2026-06-12	Zanganeh Mahkam10%	Co-Chief Executive Officer	0.7%Indirect	3,810,000	$13.12	$49.99M
Buy	2026-06-12	DUGGAN ROBERT W10%	Co-Chief Executive Officer	0.7%Direct	3,810,000	$13.12	$49.99M
Buy	2026-06-04	DUGGAN ROBERT W10%	Co-Chief Executive Officer	0.4%Indirect	100,000	$14.60	$1.46M
Buy	2026-06-04	Zanganeh Mahkam10%	Co-Chief Executive Officer	0.4%Indirect	100,000	$14.60	$1.46M
Buy	2026-06-04	Soni Manmeet Singh	COO and CFO	0.8%Direct	25,000	$14.43	$360.8K

Buy

Zanganeh Mahkam

Co-Chief Executive Officer · 0.7% of stake · 2026-06-12

$49.99M

3,810,000 @ $13.12

Buy

DUGGAN ROBERT W

Co-Chief Executive Officer · 0.7% of stake · 2026-06-12

$49.99M

3,810,000 @ $13.12

Buy

DUGGAN ROBERT W

Co-Chief Executive Officer · 0.4% of stake · 2026-06-04

$1.46M

100,000 @ $14.60

Buy

Zanganeh Mahkam

Co-Chief Executive Officer · 0.4% of stake · 2026-06-04

$1.46M

100,000 @ $14.60

Buy

Soni Manmeet Singh

COO and CFO · 0.8% of stake · 2026-06-04

$360.8K

25,000 @ $14.43

16 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →